COVID-19 Response 

Access our COVID-19 Response homepage, with more information and resources during the COVID-19 pandemic, including what to do if you’re experiencing symptoms.

Weather Update

Baylor College of Medicine will be open Wednesday and Baylor Medicine will be seeing patients. Please prioritize your safety and take appropriate safety precautions if driving in any high water. View message. 


GWAS Intake Form


To be eligible to participate in the Integral Project, studies must have:


Genome-wide genotyping data or germline DNA for genotyping, i.e.: existing genome-wide genotyping data, or germline DNA available for new genotyping, or blood/buccal samples for germline DNA isolation and genotyping. Basic phenotype data (e.g. age at diagnosis, gender, family history of breast cancer) Appropriate ethics approval for genetic studies and data sharing See the Integral Project Summary for more information, including principles and governance, and approximate timeline.

Please complete the study inventory if you are interested in participating in the Integral Project. We are performing an initial evaluation of interested studies that responded by the deadline. We will consider additional expressions of interest until reaching the desired target. This inventory is for planning purposes only and implies no commitment to participate.

PLEASE NOTE: If you have any questions, please contact the Project Manager, Kathryn Edwards, at Kathryn.Edwards@bcm.edu.